Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wilding

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitorJ Berlin, K D Tutsch, P Hutson, et al.
Pediatrics|November 3, 2006
An effective nonchemical treatment for head lice: a lot of hot airBrad M Goates, Joseph S Atkin, Kevin G Wilding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase I clinical and pharmacokinetic trial of penclomedine using a novel, two-stage trial design for patients with advanced malignancyJ Berlin, J A Stewart, B Storer, et al.
Investigational New Drugs|November 11, 1999
Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812)K D Tutsch, R Z Arzoomanian, D Alberti, et al.
Investigational New Drugs|January 19, 2000
A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancerR S Witte, S Lipsitz, T L Goodman, et al.
The Cancer Journal From Scientific American|June 5, 1998
The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferonE J Small, G R Weiss, U K Malik, et al.
British Journal of Cancer|April 27, 2016
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumoursD Mahalingam, G Wilding, S Denmeade, et al.
Investigational New Drugs|July 30, 1999
A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumorsJ D Berlin, D B Alberti, R Z Arzoomanian, et al.
Cancer|January 1, 1992
A pilot trial of chemohormonal therapy for metastatic prostate carcinomaN A Dawson, G Wilding, R B Weiss, et al.
Cancer Research|February 15, 1991
A phase I study of SR-2508 and cyclophosphamide administered by intravenous injectionH Bailey, R T Mulcahy, K D Tutsch, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitorJ Berlin, K D Tutsch, P Hutson, et al.
Pediatrics|November 3, 2006
An effective nonchemical treatment for head lice: a lot of hot airBrad M Goates, Joseph S Atkin, Kevin G Wilding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase I clinical and pharmacokinetic trial of penclomedine using a novel, two-stage trial design for patients with advanced malignancyJ Berlin, J A Stewart, B Storer, et al.
Investigational New Drugs|November 11, 1999
Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812)K D Tutsch, R Z Arzoomanian, D Alberti, et al.
Investigational New Drugs|January 19, 2000
A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancerR S Witte, S Lipsitz, T L Goodman, et al.
The Cancer Journal From Scientific American|June 5, 1998
The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferonE J Small, G R Weiss, U K Malik, et al.
British Journal of Cancer|April 27, 2016
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumoursD Mahalingam, G Wilding, S Denmeade, et al.
Investigational New Drugs|July 30, 1999
A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumorsJ D Berlin, D B Alberti, R Z Arzoomanian, et al.
Cancer|January 1, 1992
A pilot trial of chemohormonal therapy for metastatic prostate carcinomaN A Dawson, G Wilding, R B Weiss, et al.
Cancer Research|February 15, 1991
A phase I study of SR-2508 and cyclophosphamide administered by intravenous injectionH Bailey, R T Mulcahy, K D Tutsch, et al.
Pageof 11